A patient is sitting at dinner. Without warning, the panic attack begins. Within minutes they feel certain they are dying. What is happening?
The amygdala detects a threat — possibly an internal one. A faint smell, an overheard phrase, a subtle interoceptive sensation in the chest. The trigger may not even reach conscious awareness. The amygdala, working faster than cortical analysis, fires.
The hypothalamus activates the HPA axis. CRH releases. The pituitary releases ACTH. The adrenal cortex releases cortisol. The whole stress cascade we built in Stage 4 begins to fire. Glucose mobilizes. Inflammatory pathways shift.
Simultaneously, the locus coeruleus floods the cortex with norepinephrine. Heart rate climbs. Pupils dilate. Breathing accelerates. The autonomic system shifts into fight-or-flight readiness. None of this has been consciously chosen; the brain is doing it autonomously.
The insula reads the body. Anterior insula, as part of the salience network, registers the racing heart, the tight chest, the rapid breath. It generates an interoceptive signal: something is very wrong inside me. This bodily signal is broadcast to the rest of the cortex.
The cortex generates an interpretation. Faced with a racing heart and a sense of impending doom, the cortex produces a story to explain it: I am having a heart attack. I am dying. I have to get out of here. This catastrophic interpretation is wrong — the physiology is panic, not cardiac — but the cortex does not know that yet.
The interpretation feeds back to the amygdala. The thought I am dying is itself a threat signal. The amygdala fires harder. More CRH. More ACTH. More cortisol. More norepinephrine. The body responds with more arousal. The insula reads stronger bodily signals. The cortex generates a more certain interpretation of catastrophe. The amygdala fires harder still.
The system reaches a crescendo within minutes. The patient is convinced they are dying. They may go to the emergency room. They may collapse. The peak of the attack lasts perhaps ten to twenty minutes; the loop eventually exhausts itself as autonomic systems normalize.
The pharmacologic intervention with the fastest onset is a benzodiazepine, which enhances GABA at the GABA-A receptor, dampening amygdala and locus coeruleus output within ten to twenty minutes. We covered this in Stage 9. The ionotropic mechanism means rapid effect — minutes, not weeks.
The longer-term intervention is an SSRI, which over weeks reduces amygdala reactivity, partly through 5-HT2A and 5-HT1A receptor modulation, partly through hippocampal neurogenesis and altered fear learning. This is metabotropic — slow — but it changes the underlying reactivity rather than just damping the acute episode.
The non-pharmacologic intervention is interoceptive exposure, which, through cognitive-behavioral therapy, retrains the cortex's interpretation of bodily sensations. The patient learns through repeated practice that a racing heart is not always evidence of a heart attack, that anxiety sensations themselves are not dangerous, that the catastrophic appraisal can be questioned. Over time, the cortex stops generating the catastrophic interpretation, and the loop fails to start.
Notice how this single scenario uses the amygdala, the hypothalamus, the HPA axis, the locus coeruleus, the insula, the cortex, GABA, serotonin, and norepinephrine. None of these are new. We have met all of them. They are now working together as a system.